Tag: haemophilia A

March 9, 2022 Off

SOBI’s and Sanofi’s Haemophilia A Drug Met the Primary and Key Secondary Endpoints

Swedish Orphan Biovitrum (SOBI) and Sanofi have announced positive top-line results from the pivotal XTEND-1 phase 3 study evaluating the…

May 18, 2017 Off

Sobi to sell another rare disease drug in Saudi Arabia

By Dino Mustafić

The Saudi Food & Drug Authority (SFDA) has approved Swedish Orphan Biovitrum’s (Sobi) Elocta (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life, for the treatment of haemophilia A.